Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
171 studies found for:    ANGIOTENSIN I-CONVERTING ENZYME
Show Display Options
Rank Status Study
1 Completed
Has Results
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
2 Completed Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding
Conditions: Dipeptidyl-peptidase-4;   STEMI;   PCI;   No-reflow;   Bleeding
3 Recruiting ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
Conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors;   Hypotension
Interventions: Drug: Cessation group;   Drug: Continuation group
4 Completed Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
Conditions: Atherosclerosis;   Coronary Disease
5 Completed ACE Gene Polymorphism and ARDS Outcome
Condition: Adult Respiratory Distress Syndrome
6 Completed Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction
Conditions: Metabolic Syndrome;   Coronary Artery Disease
7 Active, not recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
8 Completed
Has Results
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Conditions: Coronary Artery Disease;   Angiotensin Converting Enzyme;   Angiotensin Receptor Blockers;   Cardiopulmonary Bypass;   Fibrinolysis;   Inflammation
Interventions: Drug: Placebo;   Drug: Ramipril;   Drug: Candesartan
9 Completed Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
Condition: Kidney Failure
Intervention: Drug: Hold ACEI or ARB
10 Recruiting Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: saxagliptin;   Drug: placebo
11 Recruiting Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
Conditions: Dipeptidyl-Peptidase 4 Inhibitors;   LDL Cholesterol;   Glycosylated Hemoglobin;   Diabetes Mellitus;   Coronary Disease
Interventions: Drug: Anagliptin;   Drug: Sitagliptin
12 Terminated Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children
Condition: Sickle Cell Disease
Interventions: Drug: Enalapril;   Drug: Placebo
13 Terminated Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)
Conditions: Kidney Failure, Acute;   Critical Illness
Intervention: Procedure: Blood sampling for PCR
14 Recruiting The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Sitagliptin;   Drug: Placebo
15 Recruiting Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
Condition: Coronary Artery Disease
Interventions: Drug: ACE/ARB continuation;   Drug: ACE/ARB withdrawal
16 Recruiting The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
Condition: Hypertension, Resistant to Conventional Therapy
Interventions: Drug: Equivalent dose enalapril;   Drug: Equivalent dose lisinopril
17 Completed
Has Results
The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution
Conditions: Hypertension;   Congestive Cardiomyopathy
Intervention: Drug: Enalaprilat
18 Unknown  Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angioedema
Intervention: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
19 Recruiting Arterial Stiffness and General Anesthesia Induced Hypotension in Patients on Angiotensin-converting Enzyme Inhibitors
Conditions: Hypotension;   Arterial Stiffness
Intervention: Device: SphygmoCor system
20 Completed
Has Results
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Placebo-matching dapagliflozin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years